When it comes to the next steps for anti-CGRP therapies, we need to discuss the concept of synergism, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.
When it comes to the next steps for anti-CGRP therapies, we need to discuss the concept of synergism, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.
Transcript:
The American Journal of Managed Care®(AJMC®):What are the next steps for anti-CGRP therapies?
Dr. Silberstein: What we need to do is talk about the concept of synergism. What do I mean by that? If you take drug A, or you're on an antibody, what drug would work to help it give a better result. What we need to do now is take patients who are on antibodies and find out what drugs may give additional benefit. We did that Once. We did a study with patients on topiramate, stable dose, added either propranolol or the propranolol placebo and showed propranolol added nothing. But I can tell you that in a number of the studies patients were on concomitant medication and adding antibodies to their baseline medication resulted in further improvement showing synergism and not antagonism.
AJMC®:Do you have any final thoughts you would like to share?
Dr. Silberstein:I think the biggest question now is whether if you add a botulinum toxin to an antibody is it synergistic. I think we're getting increasing evidence now that the toxins and the antibodies are synergistic. I think Rami Burstein has shown that the botulinum toxin works on the C fibers, antibodies work on the A delta fibers. In our personal experience, we're actually analyzing data now. It's been our bias that patients are attracted to 1 of the 2, you add them together, you get a better result.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More